Research and Development

Showing 15 posts of 9612 posts found.

NHS Digital lambasted for collusion with Home Office to deport migrants

January 31, 2018 Medical Communications, Research and Development NHS Digital, biotech, drugs, immigration, pharma, pharmaceutical

NHS Digital, the Department of Health and the Home Office have been strongly criticised for entering a memorandum of understanding …

Pfizer teams up with Indian Government to battle antimicrobial resistance

January 31, 2018 Medical Communications, Research and Development India, Pfizer, antimicrobial resistance, pharma

Pfizer has entered into a partnership with the Indian Council of Medical Research (ICMR) in an effort to fight antimicrobial …
2056752817_cb9ed652dd_z

Amazon makes first steps into healthcare, alongside big partners

January 31, 2018 Medical Communications, Research and Development Berkshire Hathaway, JPMorgan, amazon, biotech, drugs, pharma, pharmaceutical

Amazon’s move into the healthcare sector has been widely mooted over the last 12 months and it officially announced that …
amsterdam-1910176_960_720

Italy refuses to give up hope on EMA HQ

January 30, 2018 Medical Communications, Research and Development EMA, amsterdam, biotech, drugs, pharma, pharmaceutical

It is no secret that Milan was not best pleased that it was pipped to the post to host the …
cambridge_biomedical_campus

Delivering the life sciences agenda: Easy as ABC

January 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical

Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …

AZ’s triple therapy inhaler hits 8 out of 9 endpoints

January 26, 2018 Medical Communications, Research and Development AstraZeneca, COPD, biotech, drugs, pharma, pharmaceutical

AstraZeneca has made a brief announcement that its triple therapy inhaler manage to successfully hit eight of nine primary endpoints …
aging_-_hand

Senescent cell findings provides Parkinson’s treatment clue

January 25, 2018 Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

Senescent cells are the dormant state that cells shift to in response to certain stressors, it is thought that they …
old_man_bar

Amyloid pathway doubts after latest Alzheimer’s failure

January 25, 2018 Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …
gw_pharma

GW Pharma boasts new positive data, readying for approval

January 25, 2018 Research and Development GW Pharma, biotech, drugs, pharma, pharmaceutical

The latest data from GW Pharma is about as conclusively positive as you can usually hope to get with a …
influenza_dan_higgins_douglas_jordan_uscdcp

New vaccine provides universal protection against influenza A, study finds

January 24, 2018 Research and Development Georgia State University, Vaccine, flu, influenza, pharma

Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to …
shutterstock_92671375

US court upholds ruling that J&J’s Remicade patent is invalid

January 24, 2018 Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Remicade, biosimilars, infliximab, patent, pharma

The US Court of Appeals for the Federal Circuit has judged that Johnson & Johnson’s patent for its best-selling arthritis …
shutterstock_138095450

New York City launches $500 million lawsuit against big pharma over opioid crisis

January 24, 2018 Research and Development, Sales and Marketing New York City, opioid crisis, opioids, pharma

The administration of New York City Mayor Bill de Blasio has announced its intention to bring legal action against the …
lilly_entrance_web

Eli Lilly’s Taltz get EU approval in psoriatic arthritis subgroup

January 24, 2018 Research and Development, Sales and Marketing EU, Eli Lilly, Europe, European Commission, Taltz, pharma, psoriatic arthritis

Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …
The Gateway to Local Adoption Series

Latest content